chevron_leftBack
As of 15 June 2026, Hanshang Group Co., Ltd. has a market cap of $373.63M USD, ranking #17154 globally and #5335 in China.
It ranks #1554 in the Healthcare sector, and #561 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$373.63MUSD
2.53B CNY
Enterprise Value
$484.28MUSD
3.28B CNY
Revenue (TTM)
$152.26MUSD
1.03B CNY
EBITDA (TTM)
$21.44MUSD
145.11M CNY
Net Income (TTM)
-$25.8MUSD
-174.83M CNY
EBITDA Margin
14%
Profit Margin
-17%
PS Ratio
2.5
PB Ratio
1.6
EV/EBITDA
21.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Fang Yang
open_in_new
Employees
2,235
Founded
1990
Website
whhsg.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.2% | 2.9% | -17% | -19% | -9.1% | 7.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600774
汉商集团股份有限公司 Class A
ISIN: CNE000000NC5
Shares Out.:
Shares Outstanding:
289.008M1
Shares Float:
203.679M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
8.78 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Hanshang Group Co., Ltd.
Hanshang Group Co., Ltd. primarily engages in the retail business. It is also involved in medicine, medical equipment, assisted reproduction, healthy drinks, and exhibition operations. The company was incorporated in 1990 and is based in Wuhan, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
14K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
13K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
8K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
5K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
4K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
4K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
204K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
146K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
96K%
|
97.4
|
|
SIX: RO
|
$321.52B
86K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
77K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
73K%
218.9B CHF
|
20.5
|
chevron_leftBack